Drax exametazime and Calcitonin secretion disorder - a phase IV clinical study of FDA data
We study 7 people who take Drax exametazime or have Calcitonin secretion disorder. No report of Calcitonin secretion disorder is found in people who take Drax exametazime.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Drax Exametazime?
Drax exametazime has active ingredients of technetium tc-99m exametazime kit.
What is Calcitonin Secretion Disorder?
Calcitonin secretion disorder (hormone calcitonin secretion disease) is found to be associated with 8 drugs by eHealthMe.
Do you take Drax exametazime and have Calcitonin secretion disorder?Check whether Calcitonin secretion disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Calcitonin secretion disorder and when was it recovered:
Expand to all the drugs that have ingredients of technetium tc-99m exametazime kit:
Alternative drugs to, pros and cons of Drax exametazime:
Calcitonin secretion disorder treatments and more:
- Calcitonin secretion disorder (7 reports)
COVID vaccines that are related to Calcitonin secretion disorder:
- Calcitonin secretion disorder in Moderna COVID Vaccine
- Calcitonin secretion disorder in Pfizer BioNTech Covid Vaccine
- Calcitonin secretion disorder in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Calcitonin secretion disorder:
All the conditions that are associated with Calcitonin secretion disorder:
How the study uses the data?
The study uses data from the FDA. It is based on technetium tc-99m exametazime kit (the active ingredients of Drax exametazime) and Drax exametazime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.